Health World Mauritania: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health World Mauritania.

Press releases published on September 24, 2026

4 hours ago

Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform

Indeterminate GlobeNewswire

4 hours ago

Applied Biologics Announces Publication of New XWRAP® Translational Research Demonstrating More Favorable Wound-Healing Biology

Indeterminate GlobeNewswire

4 hours ago

HCW Biologics Announces Pricing of $1.5 Million Private Placement

Indeterminate GlobeNewswire

5 hours ago

IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan

Indeterminate GlobeNewswire

5 hours ago

Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health

Indeterminate GlobeNewswire

5 hours ago

SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma

Indeterminate GlobeNewswire

5 hours ago

Claris Bio Establishes Corporate Headquarters in San Francisco

Indeterminate GlobeNewswire

5 hours ago

Cronos Hosts 2026 Investor Day

Indeterminate GlobeNewswire

5 hours ago

Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR

Indeterminate GlobeNewswire

5 hours ago

Drug Developers Deploy In Silico Drug Safety Prediction Models From Deep Origin’s ARPA-H-Funded PREDICTS Consortium

Indeterminate GlobeNewswire

5 hours ago

Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma

Indeterminate GlobeNewswire

5 hours ago

Biolinq Shine™ Receives FDA 510(k) Clearance for Over-the-Counter Use

Indeterminate GlobeNewswire

5 hours ago

Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis

Indeterminate GlobeNewswire

5 hours ago

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

Indeterminate GlobeNewswire

5 hours ago

Precision Neuroscience Closes Oversubscribed $250M Series D Led by Pershing Square Inc., the Ackman Oxman Institute, and a Leading Life Sciences Investment Fund

Indeterminate GlobeNewswire

5 hours ago

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026

Indeterminate GlobeNewswire

5 hours ago

Nuvectis Announces NXP200 Granted Breakthrough Therapy Designation in China for BRAF V600-Mutant, Recurrent or Progressive, High-Grade Glioma

Indeterminate GlobeNewswire

5 hours ago

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

Indeterminate GlobeNewswire

5 hours ago

Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific Meeting

Indeterminate GlobeNewswire

5 hours ago

Sofwave Receives NMPA Approval in Mainland China

Indeterminate GlobeNewswire